Amy Spallone, M.D.
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Chief Infection Control Officer, Department of Ofc of Chief Operating Officer, Chief Quality Office, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Patient Quality Safety Officer, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | Albany Medical College, Albany, New York, US, MD |
| 2010 | Cornell University, Ithaca, New York, US, BS in Biological Sciences |
| 2008 | Corning Community College, Corning, New York, US, Associate in Mathematics and Sciences |
Postgraduate Training
| 2020-2021 | Infectious Diseases Advanced Research Fellowship, Baylor College of Medicine, Houston, Texas |
| 2019-2020 | Clinical Scientist Training Program Certificate of Added Qualification, Baylor College of Medicine Graduate School of Biomedical Sciences, Houston, Texas |
| 2018-2020 | Infectious Diseases Fellowship Program, Baylor College of Medicine, Houston, Texas |
| 2015-2018 | Internal Medicine Internship and Residency, Stony Brook University Hospital, Stony Brook, New York |
Experience & Service
Administrative Appointments/Responsibilities
Chief Infection Control Officer, Department of Ofc of the Chief Operating Officer, Chief Quality Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Department Patient Safety Quality Officer, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Chief Infection Control Officer, ad interim, Department of Office of the Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2023
Associate Chief Infection Control Officer, Department of Chief Quality Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - 2023
Institutional Committee Activities
Chair, Infectious Diseases Engagement & Wellness Committee, 2024 - Present
Member, Division of Internal Medicine Wellness Committee, 2024 - Present
Voting Member, Travel Oversight Committee, 2023 - Present
Chair, Infection Control Committee (ICC), 2023 - Present
Voting Member, Clinical Core Leadership Team (CCLT), 2023 - Present
Voting Member, Executive Committee of the Medical Staff (ECMS), 2023 - Present
Voting Member, Institutional Survey Readiness Steering Committee (ISRSC), 2023 - Present
Member, Infectious Diseases Engagement & Wellness Committee, 2022 - 2024
Voting Member, Institutional Patient Safety Committee (IPSC), 2022 - Present
Vice Chair, Infection Control Committee (ICC), 2022 - 2023
Voting Member, Quality Assurance Performance Improvement (QAPI), 2022 - Present
Member, Division of Internal Medicine Quality & Safety Council, 2021 - Present
Member, Steering Committee for Stem Cell Transplantation and Cellular Therapy, Infectious Diseases, 2021 - Present
Member, Antimicrobial Stewardship Committee, 2021 - Present
Honors & Awards
| 2024 | Certificate of Appreciation and Excellence, MD Anderson Cancer Center, Chief Quality Office |
| 2022 | Clinical Safety & Effectiveness Program Certificate of Successful Completion, The University of Texas MD Anderson Cancer Center Clinical Safety & Effectiveness Program |
| 2020 - 2021 | Outstanding Graduating Fellow, Baylor College of Medicine |
| 2015 | The One-to-Watch Award, Corning Community College |
| 2014 | MD Trustee Scholarship, Morris Alpert Alumni Scholarship |
| 2010 | Brooks Family Award for Swedish 1220, Cornell University |
| 2010 | Cornell Center for Materials Research Microscopy Award in Biological Category; Brooks Family Award for Swedish 1220, Cornell University |
| 2008 | Institutional Honors with Distinction, State University of New York Chancellor’s Award for Student Excellence |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Shafat, T, De-La-Rosa-Martinez, D, Khawaja, F, Jiang, Y, Spallone, A, Batista, MV, Ariza Heredia, E, Vilar-Compte, D, Ahmed, S, Becnel, M, Chemaly, RF. Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma. Open Forum Infectious Diseases 12(4), 2025. e-Pub 2025. PMID: 40177586.
- Daher, M, Khawaja, F, Spallone, A, Shigle, TL, Bhatti, MM, Vuong, NN, Ariza Heredia, E, Mulanovich, VE, Champlin, RE, Chemaly, RF. Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39826146.
- Wu, CT, Shropshire, W, Bhatti, MM, Cantu, S, Glover, I, Anand, SS, Liu, X, Kalia, A, Treangen, TJ, Chemaly, RF, Spallone, A, Shelburne, S. Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission. Infection Control and Hospital Epidemiology 46(2):129-135, 2025. e-Pub 2025. PMID: 39727230.
- Azuly, H, Shafat, T, Grupel, D, Porges, T, Abuhasira, R, Belkin, A, Deri, O, Oster, Y, Zahran, S, Horwitz, E, Horwitz, N, Khatib, H, Batista, MV, Cortez, AC, Brosh-Nissimov, T, Segman, Y, Ishay, L, Cohen, R, Atamna, A, Spallone, A, Chemaly, RF, Ramos, JC, Chowers, M, Rogozin, E, Oren, NC, Keske, Ş, Barchad, OW, Nesher, L, Nesher, L. Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies. Infectious Diseases and Therapy 14(1):167-180, 2025. e-Pub 2025. PMID: 39652286.
- Spallone A. Rapid Whole Genome Characterization of Antimicrobial Resistant Pathogens Using Long-Read Sequencing to Identify Potential Healthcare Transmission. ICHE. e-Pub 2024.
- Khawaja, F, Ahmed, S, Iyer, S, Sassine, J, Handley, G, Prakash, R, Vanwierren, T, Jackson, J, Zubovskaia, A, Ramdial, JL, Rondon, G, Patel, K, Spallone, A, Ariza Heredia, E, Mulanovich, VE, Angelidakis, G, Jiang, Y, Chemaly, RF. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy. Open Forum Infectious Diseases 11(8), 2024. e-Pub 2024. PMID: 39086466.
- Febres-Aldana, A, Khawaja, F, Morado-Aramburo, O, Shigle, TL, Rondon, G, Sassine, J, Spallone, A, Srinivasan, K, Ramdial, JL, Alousi, AM, Champlin, RE, Chen, GL, Daher, M, Rezvani, K, Ariza Heredia, E, Shpall, E, Chemaly, RF. Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis. Clinical Microbiology and Infection 30(6):803-809, 2024. e-Pub 2024. PMID: 38460821.
- Shafat, T, Grupel, D, Porges, T, Abuhasira, R, Belkin, A, Deri, O, Oster, Y, Zahran, S, Horwitz, E, Horwitz, N, Khatib, H, Batista, MV, Cortez, AC, Brosh-Nissimov, T, Segman, Y, Ishay, L, Cohen, R, Atamna, A, Spallone, A, Chemaly, RF, Ramos-Ramos, JC, Chowers, M, Rogozin, E, Oren, NC, Keske, Ş, Barchad, OW, Nesher, L. An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab. Cancer medicine 13(3), 2024. e-Pub 2024. PMID: 38400683.
- Khawaja, F, Angelidakis, G, Feldman, A, Ravi, V, Woodman, E, Bhatti, MM, Ariza Heredia, E, Elhajj, P, Spallone, A, Jiang, Y, Chemaly, RF. COVID-19 in cancer patients. Cancer medicine 12(24):22006-22022, 2023. e-Pub 2023. PMID: 38063366.
- Dib RW, Spallone A, Khawaja F. The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at A Comprehensive Cancer Center. American Journal of Infection Control 51(12):1302-1308, 2023. e-Pub 2023. PMID: 37804272.
- Khawaja F, Srinivasan K, Spallone A, Feldman A, Cantu S, Ariza-Heredia E, Dvordak T, Alousi A, Ahmed S, George M, Frenzel E, Bhatti M, Chemaly RF. Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned. Am J Infect Control 51(5):506-513, 2023. e-Pub 2022. PMID: 35901993.
- Ford, ES, Papanicolaou, GA, Dadwal, SS, Pergam, SA, Spallone, A. Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy. Transplantation and Cellular Therapy 29(5):289-292, 2023. e-Pub 2023. PMID: 36746374.
- Dib, RW, Ariza Heredia, E, Spallone, A, Chemaly, RF. Respiratory Viral Infections in Recipients of Cellular Therapies. Open Forum Infectious Diseases 10(4), 2023. e-Pub 2023. PMID: 37065990.
- Khawaja F, Daher M, Spallone A, Chemaly RF. COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy. Oncology (Williston Park) 37(2):69-77, 2023. e-Pub 2023. PMID: 36862845.
- Khawaja F, Spallone A, Kotton CN, Chemaly RF. Cytomegalovirus infection in transplant recipients: Newly approved additions to our armamentarium. Clin Microbiol Infect 29(1):44-50, 2023. e-Pub 2023. PMID: 35843567.
- Khawaja F, Prakash R, Sassine J, Handley G, VanWieren T, Angelidakis G, Iyer SP, Ramdial JL, Ahmed S, Nieto Y, Spallone A, Ariza-Heredia EJ, Chemaly R. Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center. Blood 140(1):7533-7535, 2022. e-Pub 2022.
- Spallone A, Alotaibi AS, Jiang Y, Daver N, Kontoyiannis DP. Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors. Clin Lymphoma Myeloma Leuk 22(5):305-310, 2022. e-Pub 2022. PMID: 34810120.
- Spallone A, Moran CA, Wurster S, Axell-House DB, Kontoyiannis DP. Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis. J Fungi (Basel) 8(4), 2022. e-Pub 2022. PMID: 35448611.
- Spallone A, Schwartz IS. Emerging Fungal Infections. Infect Dis Clin North Am 35(2):261-277, 2021. e-Pub 2021. PMID: 34016278.
- Spallone, A, Hemmersbach-Miller, M. The Great Masquerade. OBM Transplantation 5(2), 2021. e-Pub 2021.
- Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Dis 7(12):ofaa509, 2020. e-Pub 2020. PMID: 33403218.
- Spallone A, Hicklen RS, Kontoyiannis DP. Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive. Open Forum Infect Dis 7(7):ofaa247, 2020. e-Pub 2020. PMID: 32704512.
- Spallone, A, Dhal, U, Woc-Colburn, L, Hemmersbach-Miller, M. Histoplasmosis in Liver Transplant Recipients. OBM Transplantation 4(1), 2020. e-Pub 2020.
- Malek AE, Taremi M, Spallone A, Alvarez-Cardona JJ, Kontoyiannis DP. Necrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosupressants due to checkpoint inhibitor-induced hepatitis. J Infect 80(2):232-254, 2020. e-Pub 2020. PMID: 31705917.
- Spallone A, Woroch L, Sweeney K, Seidman R, Marcos LA. The Burden of Neurocysticercosis at a Single New York Hospital. J Pathog 2020:8174240, 2020. e-Pub 2020. PMID: 32802516.
- Spallone, A, Tobin, E, Chaturvedi, S, Qian, J. Central Nervous System Blastomycosis Without Travel to Known Endemic Area. Infectious Diseases in Clinical Practice 24(5):e30-e32, 2016. e-Pub 2016.
- Daher M, Khawaja F, Spallone A, Shigle TL, Ariza-Heredia E, Bhatti M, Chemaly RF. Real-World Experience with Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients. CMI.
Manuals, Teaching Aids, Other Teaching Publications
- Spallone A, Kontoyiannis DP. Skin lesions in a patient with acute myeloid leukemia presenting with febrile neutropenia, 2019.
Editorials
- Spallone A, Ariza-Heredia EJ, Chemaly RF. Acute and Latent Viral Infections in Immunocompromised Patients: A Tale of Brave Battles and Menacing Foes. Clin Microbiol Infect 28(10):1319-1320, 2022. PMID: 35724870.
Abstracts
- Bergin SP, Chemaly RF, Duttagupta R, Bigelow R, Dadwal SS, Hill JA, Lee YJ, Haidar G, Luk A, Drelick AC, Chin-Hong PV, Benamu E, Davis T, Wolf O, McClain MT, Maziarz EK, Madut D, Bedoya A, Gilstrap DL, Todd J, Barkauskas C, Puing A, Spallone A, McDowell BJ, Shariff D, Salsgiver E, Nanayakkara DD, Khawaja F, Papanicolaou G, Spagnoletti J, English M, Fung M, Russel P, Ibrahimi S, Pandey S, Adams S, Liang W, Nemirovich-Danchenko E, Mughar M, Dalai S, Dalai S, Cho Y, Ahmed AA, Hollemon D, Hong DK, Vaughn ML, Blauwkamp T, Vucetic Z, Romano R, Romano R, Romano R, Fowler VG, Holland TL. PICKUP: Pneumonia in the Immunocompromised - Use of the Karius Test for Detection of Undiagnosed Pathogens. Open Forum Infectious Diseases 9(Supplemement 2). e-Pub 2022.
- Spallone A, MD, Srinivasan K, MD, Sassine J, MD, Shigle TL, PharmD, Handy V, PharmD, Ramdial J, MD, Khawaja F, MBBS, Heredia EA, MD, Chemaly RF, MD, MPH, FACP, FIDSA. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis. Open Forum Infectious Diseases 8(1):S552–S553, 2021. e-Pub 2021.
- Sassine J, MD, Khawaja F, MBBS, Shank BR, PharmD, Lovell A, PharmD, Lee J, PharmD, DiPippo A, PharmD, Rausch CR, PharmD, Spallone A, MD, Heredia EA, MD, Chemaly RF, MD, MPH, FACP, FIDSA. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma. Open Forum Infectious Diseases 8(1):S557–S558, 2021. e-Pub 2021.
- Franklin A, MD, Axell-House DB, MD, Spallone A, MD, Tarrand J, MD, Kontoyiannis DP, MD. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM). Open Forum Infectious Diseases 8(1):S454,, 2021. e-Pub 2021.
- Khoo T, MD, Spallone 1A, MD, Lier 2A, MD, MPH, Abul 2Y, MD, Wellins 3A, DNP, Weinbaum 4F, MD, Luft 5B, MD, FIDSA, A Marcos 3AL, MD, MPH3. Lyme Disease in Hispanics in Long Island, New York: A New Health Disparity in the U.S. Open Forum Infectious Diseases 4(1):S308, 2017. e-Pub 2017.
- Khoo T, MD, Fleischner 1Z, MD, Chow 2R, MD, Monteforte 3M, PharmD, A Marcos 4AL, MD, MPH1. Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis. Open Forum Infectious Diseases 4(1):S386, 2017. e-Pub 2017.
- Atkinson T, Mahatme S, Spallone A, Fundin J. The Preliminary Impact of Pain Management Integration into an HIV Specialty Clinic. The Scientific Pages of Anesthesia and Pain Management 1(1):7-12, 2017. e-Pub 2017.
- Spallone A, MD, Chow R, MD, Marcos LA, MD. Epidemiology of Neurocysticercosis at Stony Brook University Hospital, Long Island, New York. Open Forum Infectious Diseases 3(1):584, 2016. e-Pub 2016.
- Abul Y, MD, Chow R, MD, Spallone A, MD, Luft B, MD, FIDSA, Marcos LA, MD. Epidemiology of Lyme Disease in Hispanics Admitted to a Tertiary Medical Center in Long Island. Open Forum Infectious Diseases 3(1):1422, 2016. e-Pub 2016.
- Layale Yaghi, PhD, Rita Wilson-Dib, MD, Sherry Cantu, MPH, Piyali Chatterjee, PhD, Chetan Jinadatha, MD, PhD, Roy Chemaly, MD, MPH, Spallone A. The efficacy of a filtered handheld far-ultraviolet disinfection device in reducing environmental pathogens from high-touch clinical surfaces in healthcare setting. ECCMID.
- Chin-Ting Wu, William Shropshire,, Micah M Bhatti,, Sherry Cantu,, Israel K Glover,, Xiaojun Liu,, Awdhesh Kalia,, Todd Treangen,, Samuel Shelburne, Spallone A. Rapid Genomic Characterization of High-Risk Pathogens Using Long-Read Sequencing to Identify Nosocomial Outbreaks. The Division of Pathology and Laboratory Medicine DPLM Annual Research Day.
- Sherry Cantu, MPH, Ha Bui,, Nadeem Prasla, Roy F Chemaly, MD, MPH,, Jane Powell, DNP, Spallone A. Automated Discontinuation of Isolation Precautions with the Use of Electronic Health Record Tools. Division of Internal Medicine Research Retreat & Poster Session.
- Adina Feldman, MPH,, Micah Bhatti, MD, PhD,, Jane Powell, DNP,, Roy Chemaly, MD, MPH, Spallone A. Prevalence of Candida auris Among High-Risk Patients at a Comprehensive Cancer Center. 2024 Division of Internal Medicine Research Retreat & Poster Session.
- Georgios Angelidakis, Tali Shafat, Layale Yaghi, Fareed Khawaja, Flavio Pignataro Oshiro, Joshua Kirsch, Ella Ariza Heredia, Marjorie Vieira Batista, Kenneth John Gollob, Breck Duerkop, Roy Chemaly, Spallone A. Outcomes of respiratory viral infections in hematopoietic cell transplant recipients and patients with leukemia: a prospective study. ID Week.
- Spallone A. Epidemiology of Neurocysticercosis at Stony Brook University Hospital, Long Island, New York. InOpen Forum Infectious Diseases 2016 Dec 1 (Vol. 3, No. suppl_1, p. 584). Oxford University Press. ID Week.
- Spallone A. Epidemiology of Lyme disease in Hispanics admitted to a tertiary medical center in Long Island. InOpen Forum Infectious Diseases 2016 Dec 1 (Vol. 3, No. suppl_1, p. 1422). Oxford University Press. ID Week.
- Spallone A. Lyme Disease in Hispanics in Long Island, New York: A New Health Disparity in the US. InOpen Forum Infectious Diseases 2017 (Vol. 4, No. Suppl 1, p. S308). Oxford University Press. ID Week.
- Spallone A. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma. InOpen Forum Infectious Diseases 2021 Nov 1 (Vol. 8, No. Supplement_1, pp. S557-S558). US: Oxford University Press. ID Week.
- Spallone A. Comparison of Initial CXR to CT in Patients (pts) with Hematologic Malignancy (HEM) and Documented Symptomatic Pulmonary Mucormycosis (PM). ID Week.
- Spallone A. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis. InOpen Forum Infectious Diseases 2021 Nov 1 (Vol. 8, No. Supplement_1, pp. S552-S553). US: Oxford University Press. ID Week.
- Spallone A. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis. InOpen Forum Infectious Diseases 2021 Nov 1 (Vol. 8, No. Supplement_1, pp. S552-S553). US: Oxford University Press. ID Week.
- Spallone A. Pneumonia in the Immunocompromised-Use of the Karius Test for Detection of Undiagnosed Pathogens. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-597). US: Oxford University Press. ID Week.
- Spallone A. Long term hematopoietic cell transplant outcomes in patients at high risk for cytomegalovirus infections in the era of letermovir. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-112). US: Oxford University Press. ID Week.
- Spallone A. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic. Transplantation and Cellular Therapy. 2022 Mar;28(3):S375. ASTCT.
- Spallone A. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-1743). US: Oxford University Press. ID Week.
- Spallone A. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-1742). US: Oxford University Press. ID Week.
- Spallone A. Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B. 1.1. 529 In a Comprehensive Cancer Center. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-1541). US: Oxford University Press. ID Week.
- Spallone A. Herpesviruses Infections in CAR T Cell Recipients. In2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2022 Apr 24. Tandem Meetings. ASTCT.
- Spallone A. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-1740). US: Oxford University Press. ID Week.
- Spallone A. The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at a Comprehensive Cancer Center. InOpen Forum Infectious Diseases 2022 Dec 1 (Vol. 9, No. Supplement_2, pp. ofac492-1042). US: Oxford University Press. ID Week.
- Spallone A, Khawaja F, Ariza-Heredia E, Papanicolaou GA, Boeckh MJ, Dadwal SS, Abidi MZ, Camargo JF, El Boghdadly Z, Shahid Z, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic. ASTCT.
- Spallone A, Khawaja F, Ariza-Heredia E,, Papanicolaou GA,, Boeckh MJ,, Dadwal SS,, Abidi MZ,, Camargo JF,, El Boghdadly Z,, Shahid Z,, Chemaly RF. Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic. ECCMID.
- Fareed Khawaja, Carmen Sadaka,, Samantha Trager,, Kerri Fernandes,, Ella J. Ariza-Heredia, Spallone A, Michelle Altrich,, Roy F. Chemaly. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia. ICHS.
- Spallone A, Rita Wilson Dib, MD, Fareed Khawaja, MBBS, Roy F Chemaly, MD, MPH. Hospital onset SARS CoV-2 infections before and after the emergence of the highly transmissible variant B.1.1.529 in a comprehensive cancer center. ICHS.
- Spallone A, Rita Wilson Dib, MD, Fareed Khawaja, MBBS, Roy F Chemaly, MD, MPH. The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. ICHS.
- Fareed Khawaja, Rishab Prakash, Joseph Sassine, Guy Handley, Tracy VanWieren, Georgios Angelidakis, Swaminathan P. Iyer, Jeremy L. Ramdial, Sairah Ahmedy, Yago Nieto, Ella J. Ariza-Heredia, Spallone A, Roy Chemaly. Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center. ASTCT.
- Spallone A. Human Herpes Virus 6 Dnaemia within 1 Year of Chimeric Antigen Receptor T Cell Therapy. In2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2023 Feb 16. Tandem Meetings. ASTCT.
- Spallone A. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes, Open Forum Infectious Diseases, Volume 10, Issue. ID Week.
- Spallone A. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge. ID Week.
- Sherry Cantu, Spallone A, Roy Chemaly, Jane Elizabeth Powell, Ha Bui, Nadeem Prasla. Automated Discontinuation of Isolation Precautions with the Use of Electronic Health Record Tools. SHEA.
- Spallone A, Rita Wilson Dib, MD, Fareed Khawaja, MBBS, Roy F Chemaly, MD, MPH. Hospital-acquired infections on the COVID-19 units at a comprehensive cancer centre. ECCMID.
- Rita Wilson Dib, Adrienne Gonzales, Spallone A, Victor Mulanovich. Relapsing Pseudomonas aeruginoa bacteremia: Where did it come from?. ECCMID.
- Chin-Ting Wu, William Shropshire,, Micah M Bhatti,, Sherry Cantu,, Israel K Glover,, Xiaojun Liu,, Awdhesh Kalia,, Todd Treangen,, Samuel Shelburne, Spallone A. Rapid Genomic Characterization of High-Risk Pathogens Using Long-Read Sequencing to Identify Nosocomial Outbreaks. Nanopore Community Meeting.
- Chin-Ting Wu, William Shropshire, Micah M Bhatti, Sherry Cantu, Israel K Glover, Xiaojun Liu, Awdhesh Kalia, Todd Treangen, Samuel Shelburne, Spallone A. Rapid Genomic Characterization of High-Risk Pathogens Using Long-Read Sequencing to Identify Nosocomial Outbreaks. 7th Annual Texas Medical Center AMR & Stewardship Conference.
- Layale Yaghi, PhD, Rita Wilson-Dib, MD, Sherry Cantu, MPH, Piyali Chatterjee, PhD, Chetan Jinadatha, MD, PhD, Roy Chemaly, MD, MPH, Spallone A. The efficacy of a filtered handheld far-ultraviolet disinfection device in reducing environmental pathogens from high-touch clinical surfaces in healthcare setting. ICHS.
- Layale Yaghi, PhD, Rita Wilson-Dib, MD, Sherry Cantu, MPH, Piyali Chatterjee, PhD, Chetan Jinadatha, MD, PhD, Roy Chemaly, MD, Spallone A. The efficacy of a filtered handheld far-ultraviolet disinfection device in reducing environmental pathogens from high-touch clinical surfaces in healthcare setting. SHEA.
- Adina Feldman, Micah Bhatti, Jane Powell, Roy Chemaly, Spallone A. Prevalence of Candida auris Among High-Risk Patients at a Comprehensive Cancer Center. SHEA.
- Adina Feldman, Sherry Cantu, Hilary McMurry, Crystal Odom, Leila Nahavandi, Jane Powell, Spallone A. Improving Data Quality from a Hematology Unit Hand Hygiene Observation Program. SHEA.
- Chin-Ting Wu, Spallone A, Sherry Cantu, Todd Treangen, William Shropshire, Micah Bhatti, Israel Glover, Xiaojun Liu, Samuel Shelburne, Awdhesh Kalia. Rapid Genomic Characterization of High-Risk, Antibiotic Resistant Pathogens Using Long-Read Sequencing to Identify Nosocomial Outbreaks. SHEA.
- Kim Nguyen, Spallone A, Holly Ayers, Mymimilami Santos, Maryam Zaghian, Karim Samir Abdeldaem, Adriana Wechsler. Reducing Blood Culture Contamination in Adult Patients with Cancer Presenting to the Emergency Department. SHEA.
Book Chapters
- Franklin, A, Spallone, A, Chemaly, RF. Cytomegalovirus Diseases in Hematopoietic Cell Transplant Recipients. In: Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Springer International Publishing, 141-160, 2024.
- Daniel Musher ASA. Haemophilus. In: Schlossberg's Clinical Infectious Disease. 3rd. Oxford University Press, 2022.
- Spallone A, Woc-Colburn L. Mycoses. In: Case Files: Microbiology. 4th. McGraw-Hill.
Books (edited and written)
- Roy Chemaly, Steve Pergam, Spallone A. Infection Control in Immunocompromised Patients. Springer.
Selected Presentations & Talks
Local Presentations
- 2024. COVID-19 Updates. Invited. Clinical Enterprise Leaders Live. Houston, Texas, US.
- 2024. Respiratory Virus Report and Updated COVID-19 Protocols. Invited. Clinical Enterprise Leaders Live. Houston, Texas, US.
- 2024. COVID-19 Perspectives and the Path Forward. Invited. President’s Advisory Council. Houston, Texas, US.
- 2024. Keynote Speaker: The What, Why, and How of Quality Improvement. Invited. MD Anderson 2024 Division of Pharmacy Quality and Research Celebration. Houston, Texas, US.
- 2024. COVID-19 Perspectives and the Path Forward. Invited. Core Clinical Leadership Team. Houston, Texas, US.
- 2024. Staying Alert: Update on Measles in the U.S. Invited. Clinical Enterprise Leaders Live. Houston, Texas, US.
- 2024. Infection Control Update – Respiratory Viral Season. Invited. Core Clinical Leadership Team. Houston, Texas, US.
- 2023. COVID-19 De-escalation Updates. Invited. Clinical Enterprise Leaders Live. Houston, Texas, US.
- 2023. COVID-19 Updates. Invited. Core Clinical Leadership Team. Houston, Texas, US.
- 2023. COVID-19 Updates & Infection Control Recommendations. Invited. Core Clinical Leadership Team. Houston, Texas, US.
- 2022. Monkeypox Global-to-Local Updates. Invited. Infection Control Committee. Houston, Texas, US.
- 2022. Monkeypox update. Invited. PA Senate Meeting. Houston, Texas, US.
- 2022. Monkeypox Outbreak and Updates. Invited. ID-APP Lunch & Learn. Houston, Texas, US.
- 2022. Institutional Monkeypox education. Invited. APRN Counsel Meeting. Houston, Texas, US.
- 2022. Monkeypox Outbreak 2022. Invited. ICT Grand Rounds. Houston, Texas, US.
- 2022. Institutional Monkeypox education. Invited. APP Managers/Supervisors Forum. Houston, Texas, US.
- 2022. Monkeypox update. Invited. Infectious Diseases Case Conference. Houston, Texas, US.
- 2022. Institutional Monkeypox education. Invited. Ambulatory Leaders Forum. Houston, Texas, US.
- 2022. Institutional Townhall and Q&A on Monkeypox. Invited. LGBTQ+ Community Townhall. Houston, Texas, US.
- 2022. Institutional Monkeypox Education. Invited. Acute Care Center/Clinical Decision Making Unit Staff Meeting. Houston, Texas, US.
- 2022. Monkeypox Updates. Invited. Infection Control Committee. Houston, Texas, US.
- 2022. Institutional Monkeypox Education. Invited. International Center. Houston, Texas, US.
- 2022. Monkeypox Outbreak 2022. Invited. LGBTQ+ Network Meeting. Houston, Texas, US.
- 2022. Monkeypox updates. Invited. Infection Control Committee. Houston, Texas, US.
National Presentations
- 2023. Post COVID-19 Implications: The Lasting Impact on a Comprehensive Cancer Center. Invited. Scripps MD Anderson Cancer Center’s 2023 Cancer Care Symposium. San Diego, CA, US.
- 2023. The COVID-19 Pandemic: The Impact on a Comprehensive Cancer Hospital. Invited. 2023 Cancer Network Speaker's Bureau, US.
International Presentations
- 2023. Prevention of RVIs: Infection control, vaccines, monoclonals and antivirals. Invited. ESCMID Postgraduate Educational Course: Update on Infections in Immunocompromised Host. Basel, CH.
- 2022. Hospital-acquired COVID-19 and other respiratory viral infections during the pandemic: What we learned. Invited. ESGREV/ESCMID Webinar: The Interplay of Respiratory Viruses and COVID-19: Re-emergence of Respiratory Viral Seasonality and the New Normal After the Pandemic. Basel, CH.
- 2022. Taking a closer look: Clinical and histopathological characteristics of culture-positive versus culture-negative pulmonary mucormycosis. Invited. 10th Advances Against Aspergillosis and Mucormycosis. Manchest, GB.
Formal Peers
- 2024. Stem Cell Therapy Quality Meeting. Houston, Texas, US.
- 2024. Candida auris Screening and Monitoring in the ICU. Houston, Texas, US.
- 2024. Infection Control Updates. Houston, Texas, US.
- 2023. Stem Cell Therapy Quality Meeting. Houston, Texas, US.
- 2023. Infection Control Updates. Houston, Texas, US.
- 2023. Stem Cell Transplant Quality Meeting. Houston, Texas, US.
- 2023. Infection Control Updates. Houston, Texas, US.
- 2022. Infection Control Updates. Houston, Texas, US.
- 2018. Medically Significant Zoonosis of Cats and Dogs. Invited. Ithaca, NY, US.
- 2014. Post Travel Fever. Invited. Albany, NY, US.
Grant & Contract Support
| Date: | 2022 - Present |
| Title: | The impact of a Filtered Far ultraviolet-C handheld disinfection device on reducing healthcare environmental pathogens from high-touch surfaces in clinical working rooms |
| Funding Source: | FreeStyle, LLC |
| Role: | PI |
| ID: | AWD00006978 |
| Date: | 2020 - 2021 |
| Title: | Infection and Immunity NIH T32 AI055413 Training Grant |
| Funding Source: | NIH/NIAID |
| Role: | Postdoctoral Fellow |
| ID: | T32 AI055413 Training Grant |
Patient Reviews
CV information above last modified June 20, 2025